Guo Ergang, Wu Cheng, Ming Jun, Zhang Wei, Zhang Linli, Hu Guoqing
Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan.
Front Genet. 2021 Jan 8;11:593039. doi: 10.3389/fgene.2020.593039. eCollection 2020.
DNA damage repair plays an important role in cancer's initiation and progression, and in therapeutic resistance. The prognostic potential of damage repair indicators was studied in the case of clear cell renal cell carcinoma (ccRCC). Gene expression profiles of the disease were downloaded from cancer genome databases and gene ontology was applied to the DNA repair-related genes. Twenty-six differentially expressed DNA repair genes were identified, and regression analysis was used to identify those with prognostic potential and to construct a risk model. The model accurately predicted patient outcomes and distinguished among patients with different expression levels of immune evasion genes. The data indicate that DNA repair genes can be valuable for predicting the progression of clear cell renal cell carcinoma and the clinical benefits of immunotherapy.
DNA损伤修复在癌症的发生、发展以及治疗耐药性方面发挥着重要作用。我们研究了损伤修复指标在透明细胞肾细胞癌(ccRCC)中的预后潜力。从癌症基因组数据库下载了该疾病的基因表达谱,并将基因本体论应用于DNA修复相关基因。鉴定出26个差异表达的DNA修复基因,并使用回归分析来确定具有预后潜力的基因并构建风险模型。该模型准确地预测了患者的预后,并区分了免疫逃逸基因表达水平不同的患者。数据表明,DNA修复基因对于预测透明细胞肾细胞癌的进展和免疫治疗的临床益处具有重要价值。